Effects of ketamine on pulmonary TLR4 expression and NF-κ-B activation during endotoxemia in rats

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 29, Issue 6, 2007, Pages 395-399

  Yu, M ^a   Shao, D ^a   Feng, X ^a   Duan, M ^a   Xu, Ju ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Endotoxin; Ketamine; Lung; Nuclear factor B; Toll like receptor 4

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KETAMINE; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTOXEMIA; GEL MOBILITY SHIFT ASSAY; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; LUNG; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANESTHETICS, DISSOCIATIVE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTOXEMIA; KETAMINE; LIPOPOLYSACCHARIDES; LUNG; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4;

EID: 35348954353     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2007.29.6.1119165     Document Type: Article

References (35)

1. Ulevitch, R.J., Tobias, P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995, 13: 437-57.
2. Danner, R.L., Elin, R.J., Hosseini, J.M., Wesley, R.A., Reilly, J.M., Parillo, J.E. Endotoxemia in human septic shock. Chest 1991, 99: 169-75.
3. Welbourn, C.R., Young, Y. Endotoxin, septic shock and acute lung injury: Neutrophils, macrophages and inflammatory mediators. Br J Surg 1992, 79: 998-3.
4. Liu, Z., Yu, Y., Jiang, Y., Li, J. Growth hormone increases lung NF-kappa B activation and lung microvascular injury induced by lipopolysaccharide in rats. Ann Clin Lab Sci 2002, 32: 164-70.
5. Chang, S.W. Endotoxin-induced pulmonary leukostasis in the rat: Role of platelet-activating factor and tumor necrosis factor. J Lab Clin Med 1994, 123: 65-72.
6. Ghosh, S., May, M.J., Kopp, E.B. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998, 16: 225-60.
7. Ivankovich, A.D., Miletich, D.J., Reimam, C., Albrecht, R.F., Zahed, B. Cardiovascular effects of centrally administered ketamine in goats. Anesth Analg 1974, 53: 924-33.
8. Lippmann, M., Appel, P.L., Mok, M.S., Shoemaker, W.C. Sequential cardiorespiratory patterns of anesthetic induction with ketamine in critically ill patients. Crit Care Med 1983, 11: 730-4.
9. Kawasaki, T., Ogata, M., Kawasaki, C., Ogata, J., Inoue, Y., Shigematsu, A. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 1999, 89: 665-9.
10. Koga, K., Ogata, M., Takenaka, I., Matsumoto, T., Shigematsu, A. Ketamine suppresses tumor necrosis factor-alpha activity and mortality in carrageenan-sensitized endotoxin shock model. Circ Shock 1994, 44: 160-8.
11. Takenaka, I., Ogata, M., Koga, K., Matsumoto, T., Shigematsu, A. Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice. Anesthesiology 1994, 80: 402-8.
12. Sun, J., Zhou, Z.Q., Lv, R., Li, W.Y., Xu, J.G. Ketamine inhibits LPS-induced calcium elevation and NF-kappa B activation in monocytes. Inflamm Res 2004, 53: 304-8.
13. Yu, Y., Zhou, Z., Xu, J., Liu, Z., Wang, Y. Ketamine reduces NF kappa B activation and TNF alpha production in rat mononuclear cells induced by lipopolysaccharide in vitro. Ann Clin Lab Sci 2002, 32: 292-8.
14. Sun, J., Li, F., Chen, J., Xu, J. Effect of ketamine on NF-kappa B activity and TNF-alpha production in endotoxin-treated rats. Ann Clin Lab Sci 2004, 34: 181-6.
15. Medzhitov, R., Preston-Hurlburt, P., Janeway, C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388: 394-7.
16. Poltorak, A., He, X., Smirnova, I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in TLR4 gene. Science 1998, 282: 2085-8.
17. Qureshi, S.T., Lariviere, L., Leveque, G. et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999, 189: 615-25.
18. Chow, J.C., Young, D.W., Golenbock, D.T., Christ, W.J., Gusovsky, F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999, 274: 10689-92.
19. Pang, Z.J., Xing, F.Q. Expression of transforming growth factor-beta and insulin-like growth factor in molar and placental tissues. Arch Gynecol Obstet 2003, 269: 1-4.
20. Li, X.N., Ding, Y.Q., Liu, G.B. Transcriptional gene expression profiles of HGF/SF-met signaling pathway in colorectal carcinoma. World J Gastroenterol 2003, 9: 1734-8.
21. Medzhitov, R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1: 135-45.
22. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J.M., Hoffmann, J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosphila adults. Cell 1996, 86: 973-83.
23. Schumann, R.R., Leong, S.R., Flaggs, G.W. et al. Structure and function of lipopolysaccharide binding protein. Science 1990, 249: 1429-36.
24. Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J., Mathison, J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding-protein. Science 1990, 249: 1431-3.
25. Akashi, S., Ogata, H., Kirikae, F. et al. Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. Biochem Biophys Res Commun 2000, 268: 172-7.
26. Hoshino, K., Takeuchi, O., Kawai, T. et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J Immunol 1999, 162: 3749-52.
27. Muzio, M., Ni, J., Feng, P., Dixit, V.M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997, 278: 1612-5.
28. Cao, Z., Henzel, W.J., Gao, X. IRAK: A kinase associated with the interleukin-1 receptor. Science 1996, 271: 1128-31.
29. Cao, Z., Xiong, J., Takeuchi, M., Kurama, T., Goeddel, D.V. TRAF6 is a signal transducer for interleukin-1. Nature 1996, 383: 443-6.
30. Karin, M., Ben-Neriah, Y. Phosphorylation meets ubiquitination: The control of NF-kappa B activity. Annu Rev Immunol 2000, 18: 621-63.
31. Williams, D.L., Ha, T., Li, C. et al. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit Care Med 2003, 31: 1808-18.
32. Schulze-Ostehoff, K., Ferrari, D., Riehemann, K., Wesselborg, S. Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology 1997, 198: 35-49.
33. Kane, L.P., Shapiro, V.S., Stokoe, D., Weiss, A. Induction of NF-kappa B by the Akt/PKB kinase. Curr Biol 1999, 9: 601-4.
34. Lee, J.Y., Ye, J., Gao, Z. et al. Reciprocal modulation of toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 2003, 278: 37041-51.
35. Mirza, A., Eder, V., Rochefort, G.Y. et al. CO inhalation at dose corresponding to tobacco smoke worsens cardiac remodeling after experimental myocardial infarction in rats. Toxicol Sci 2005, 85: 976-82.